Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine. 2012 Dec 17; 31(1):159-64.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.